Research programme: smallpox vaccines - Tonix Pharmaceuticals

Drug Profile

Research programme: smallpox vaccines - Tonix Pharmaceuticals

Alternative Names: TNX 801

Latest Information Update: 14 Jul 2014

Price : $50

At a glance

  • Originator Leder Laboratories
  • Developer Tonix Pharmaceuticals Holding Corp
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Research Smallpox

Most Recent Events

  • 28 Mar 2014 Early research in Smallpox (prevention) in USA (unspecified route)
  • 18 Mar 2014 Tonix Pharmaceuticals Holding Corp acquires smallpox vaccines from Leder Laboratories
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top